Determination of the Aggregate Binding Site of Amyloid Protofibrils Using Electron Capture Dissociation Tandem Mass Spectrometry
- 10 January 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Society for Mass Spectrometry
- Vol. 31 (2) , 267-276
Abstract
Amyloid fibril formation is a hallmark in a range of human diseases. Analysis of the molecular details of amyloid aggregation, however, is limited by the difficulties in solubilizing, separating, and identifying the aggregated biomolecules. Additional labeling or protein modification is required in many current analytical techniques in order to provide molecular details of amyloid protein aggregation, but these modifications may result in protein structure disruption. Herein, ultrahigh resolution mass spectrometry (MS) with electron capture dissociation tandem MS (ECD MS/MS) has been applied to monitor the formation of early oligomers of human islet amyloid polypeptide (hIAPP), which aggregate rapidly in the pancreas of type II diabetes (T2D) patients. ECD MS/MS results show the aggregation region of the early oligomers is at the Ser-28/Ser-29 residue of a hIAPP unit and at the Asn-35 residue of another hIAPP unit near the C-terminus in the gas phase. These data contribute to the understanding of the binding site between hIAPP units which may help for specific target region therapeutic development in the future. Furthermore, MS has also been applied to quantify the amount of soluble amyloid protein remaining in the incubated solutions, which can be used to estimate the aggregation rate of amyloid protein during incubation (28 days). These data are further correlated with the results obtained using fluorescence spectroscopy and transmission electron microscopy (TEM) to generate a general overview of amyloid protein aggregation. The methods demonstrated in this article not only explore the aggregation site of hIAPP down to an amino acid residue level, but are also applicable to many amyloid protein aggregation studies.Keywords
Funding Information
- Engineering and Physical Sciences Research Council (EP/F034210/1, EP/J000302/1, EP/N021630/1)
- H2020 European Research Council (731077)
- Biotechnology and Biological Sciences Research Council (BB/R022399, BB/P021875)
This publication has 57 references indexed in Scilit:
- A Clear View of Polymorphism, Twist, and Chirality in Amyloid Fibril FormationACS Nano, 2013
- Islet amyloid polypeptide toxicity and membrane interactionsProceedings of the National Academy of Sciences, 2013
- Ion mobility–mass spectrometry reveals a conformational conversion from random assembly to β-sheet in amyloid fibril formationNature Chemistry, 2010
- Peptide Conformation and Supramolecular Organization in Amylin Fibrils: Constraints from Solid-State NMRBiochemistry, 2007
- Molecular basis for amyloid fibril formation and stabilityProceedings of the National Academy of Sciences, 2005
- Islet amyloid and type 2 diabetes: from molecular misfolding to islet pathophysiologyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2001
- Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapyProceedings of the National Academy of Sciences, 2000
- Amyloid diseases: Abnormal protein aggregation in neurodegenerationProceedings of the National Academy of Sciences, 1999
- Amylin and the amylin gene: structure, function and relationship to islet amyloid and to diabetes mellitusBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1989
- HIGH-RESOLUTION ELECTRON MICROSCOPIC ANALYSIS OF THE AMYLOID FIBRILJournal of Cell Biology, 1967